Certain Common Shares of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 12-DEC-2024. These Common Shares will be under lockup for 91 days starting from 12-SEP-2024 to 12-DEC-2024.

Details:
Executive officers, directors and their affiliates have agreed, for a period of three (3) months from the date of this prospectus supplement, not to, directly or indirectly, offer, pledge, sell, contract to sell, grant, lend or otherwise transfer or dispose of any of shares of common shares (including any shares that such person acquires the power of disposition), enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of common shares, make any demand for or exercise any right or cause to be filed a registration statement, including any amendments thereto, with respect to the registration of any common shares or securities convertible into or exercisable or exchangeable for common shares or any other of our securities or publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement relating to such common shares, subject to customary exceptions, without the prior written consent of the placement agent.